| Multiple Ascending Dose Study of AMG 598 in Adults With Obesity (NCT03757130) | Amgen | 2018-11-26 |
| DWELL: Design For Wellness - An Online Intervention To Create Healthier Home Environments (NCT03736525) | Laura J. Rosen | 2018-11-25 |
| Evaluation of CCR2 in Patients Post Myocardial Infarction (NCT05107596) | Washington University School of Medicine | 2018-11-24 |
| Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT. (NCT04930679) | Centre of Clinical Pharmacology, Hanoi Medical University | 2018-11-24 |
| A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy (NCT03754764) | Chinese PLA General Hospital | 2018-11-23 |
| Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin (NCT03673527) | LEO Pharma | 2018-11-22 |
| Palatability (Taste) of Oral Formulations of Bosutinib (NCT03747679) | Pfizer | 2018-11-22 |
| Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults (NCT03766724) | Dong-A ST Co., Ltd. | 2018-11-22 |
| OH2 Injection in Solid Tumors (NCT04386967) | Binhui Biopharmaceutical Co., Ltd. | 2018-11-22 |
| A Study of LY3415244 in Participants With Advanced Solid Tumors (NCT03752177) | Eli Lilly and Company | 2018-11-22 |
| VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma (NCT03750071) | Vaximm GmbH | 2018-11-21 |
| HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human (NCT03758456) | HAL Allergy | 2018-11-21 |
| The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects (NCT03655873) | Sunshine Lake Pharma Co., Ltd. | 2018-11-21 |
| Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care. (NCT03780894) | Banc de Sang i Teixits | 2018-11-21 |
| A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors (NCT04941339) | Shanghai Miracogen Inc. | 2018-11-21 |
| Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants (NCT03742336) | Pfizer | 2018-11-21 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy (NCT03748979) | Takeda | 2018-11-21 |
| MGC018 With or Without MGA012 in Advanced Solid Tumors (NCT03729596) | MacroGenics | 2018-11-21 |
| A Study of LY3374849 in Healthy Participants (NCT03726125) | Eli Lilly and Company | 2018-11-20 |
| A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy Subjects (NCT04556110) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2018-11-20 |
| A Study Comparing Two Topicals in the Treatment of Acne Vulgaris (NCT03743038) | Vyne Therapeutics Inc. | 2018-11-20 |
| Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma (NCT03704714) | Northwestern University | 2018-11-20 |
| DC Vaccine in Pancreatic Cancer (NCT03592888) | University of Pennsylvania | 2018-11-20 |
| Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets (NCT03791125) | Peking University First Hospital | 2018-11-20 |
| A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers (NCT03751202) | Respirent Pharmaceuticals Co Ltd. | 2018-11-20 |
| SHR-1701 in Metastatic or Locally Advanced Solid Tumors (NCT03710265) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-20 |
| Generation of Biological Samples Positive to Salmeterol for Anti-Doping Control (NCT04195867) | Parc de Salut Mar | 2018-11-20 |
| A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers (NCT03769454) | Panoptes Pharma GmbH | 2018-11-20 |
| A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC (NCT03741712) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-20 |
| Safety, Tolerability, Pharmacokinetic Characteristics of hzVSF-v13 in Healthy Male Volunteers (NCT03653208) | ImmuneMed, Inc. | 2018-11-20 |
| Effect of Probiotic on Depression (NCT04567147) | China Agricultural University | 2018-11-20 |
| A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years (NCT04072497) | Shanghai Institute Of Biological Products | 2018-11-20 |
| A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China (NCT03565003) | Jacobio Pharmaceuticals Co., Ltd. | 2018-11-20 |
| A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 (NCT03555955) | Jazz Pharmaceuticals | 2018-11-20 |
| Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors (NCT03491631) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-20 |
| Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma (NCT03704298) | Kite, A Gilead Company | 2018-11-20 |
| Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer (NCT02842125) | MultiVir, Inc. | 2018-11-20 |
| PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects (NCT03581305) | National Institutes of Health Clinical Center (CC) | 2018-11-20 |
| Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) (NCT03663166) | H. Lee Moffitt Cancer Center and Research Institute | 2018-11-20 |
| A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms (NCT04339400) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-11-20 |
| A Study of Guselkumab in Participants With Familial Adenomatous Polyposis (NCT03649971) | Janssen Research & Development, LLC | 2018-11-19 |
| A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis (NCT03733353) | Evelo Biosciences, Inc. | 2018-11-19 |
| A Study Comparing User Experience of Different Delivery Devices for Glucagon (NCT03765502) | Eli Lilly and Company | 2018-11-19 |
| A Study of Parenterally-administered Teverelix TFA in Healthy Male Volunteers (NCT03781947) | Antev Ltd. | 2018-11-19 |
| Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) (NCT03790332) | Pharmacyclics LLC. | 2018-11-19 |
| A Study of LY3090106 in Japanese and Caucasian Healthy Participants (NCT03736772) | Eli Lilly and Company | 2018-11-19 |
| Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555) (NCT03665597) | Merck Sharp & Dohme LLC | 2018-11-19 |
| Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas (NCT03696355) | St. Jude Children's Research Hospital | 2018-11-19 |
| A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects (NCT03748745) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2018-11-19 |
| A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies (NCT03720678) | Arcus Biosciences, Inc. | 2018-11-18 |
| Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects (NCT05786339) | The Affiliated Hospital of Qingdao University | 2018-11-17 |
| CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig (NCT03383055) | Masonic Cancer Center, University of Minnesota | 2018-11-16 |
| Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC (NCT03711422) | National Cancer Centre, Singapore | 2018-11-16 |
| Drug Interaction Study of Simvastatin and Dabigatran (NCT03728101) | Korea University Guro Hospital | 2018-11-16 |
| Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas (NCT03603379) | University Hospital, Basel, Switzerland | 2018-11-16 |
| Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model (NCT03707041) | Medicines for Malaria Venture | 2018-11-16 |
| Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection (NCT04178044) | Genor Biopharma Co., Ltd. | 2018-11-16 |
| Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Subjects (NCT05967377) | Xspray Pharma AB | 2018-11-16 |
| Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis (NCT03594487) | Jeffrey Gelfand | 2018-11-16 |
| A Study to Compare the Bioequivalence and Safety of JHL1101 and Rituximab in CD20 Positive B Cell Lymphoma Patients (NCT03670888) | JHL Biotech, Inc. | 2018-11-16 |
| Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers (NCT03605277) | Novartis Pharmaceuticals | 2018-11-16 |
| Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (NCT03624036) | Kite, A Gilead Company | 2018-11-15 |
| A Study to Evaluate the Effects of ACT-541468 on Respiration in Patients With Moderate Chronic Obstructive Pulmonary Disease (NCT03646864) | Idorsia Pharmaceuticals Ltd. | 2018-11-15 |
| Pain Medications Following Thyroidectomy and Parathyroidectomy (NCT03640247) | MetroHealth Medical Center | 2018-11-15 |
| Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells (NCT03778346) | The Sixth Affiliated Hospital of Wenzhou Medical University | 2018-11-15 |
| Intra Articular Injection of Microfat and PRP in Knee Osteoarthritis (NCT04352075) | Clinique Juge | 2018-11-15 |
| Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses (NCT03735810) | RBP4 Pty Ltd | 2018-11-15 |
| Technology Enhanced Family Treatment (NCT03913013) | University of California, Los Angeles | 2018-11-15 |
| Ascending Dose Tolerability Trial and PK Assessment in Healthy Volunteers After Single & Multiple Oral Intake of DF2755A (NCT04803396) | Dompé Farmaceutici S.p.A | 2018-11-15 |
| Nilotinib in Huntington's Disease (NCT03764215) | Georgetown University | 2018-11-15 |
| Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis (NCT03685747) | Thomas Jefferson University | 2018-11-15 |
| Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients (NCT03449238) | Weill Medical College of Cornell University | 2018-11-15 |
| Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B (NCT03672188) | Vir Biotechnology, Inc. | 2018-11-14 |
| Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements (NCT03760042) | Pfizer | 2018-11-14 |
| Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs (NCT03709355) | Viriom | 2018-11-14 |
| Phase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242 (NCT03785054) | Nxera Pharma UK Limited | 2018-11-14 |
| Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia (NCT03513484) | Northwestern University | 2018-11-14 |
| ADVM-022 Intravitreal Gene Therapy for Wet AMD (NCT03748784) | Adverum Biotechnologies, Inc. | 2018-11-14 |
| First in Humans to Evaluate Collagen Patches With Stem Cells in Patients With Ischemic Left Ventricular Dysfunction (NCT03746938) | Viscofan | 2018-11-13 |
| MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer (NCT03767335) | Menarini Group | 2018-11-13 |
| Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors (NCT03744468) | BeiGene | 2018-11-13 |
| A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors (NCT03734926) | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 2018-11-13 |
| A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B (NCT03714152) | Assembly Biosciences | 2018-11-13 |
| Pharmacokinetic, Safety, Tolerability, Immunogenicity, and Pharmacodynamic Study of SB12 in Healthy Subjects (NCT03722329) | Samsung Bioepis Co., Ltd. | 2018-11-13 |
| Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. (NCT03356483) | Yale University | 2018-11-13 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 894416 in the Blood (NCT03722173) | Boehringer Ingelheim | 2018-11-13 |
| Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies (NCT03722186) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-13 |
| Gene Therapy for Children With CLN3 Batten Disease (NCT03770572) | Neela Therapeutics | 2018-11-13 |
| Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma (NCT03617328) | Craig L Slingluff, Jr | 2018-11-13 |
| Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects (NCT04411875) | The Affiliated Hospital of Qingdao University | 2018-11-13 |
| Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory CD19-positive Lymphoma. (NCT03720457) | Hrain Biotechnology Co., Ltd. | 2018-11-13 |
| Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS (NCT03300492) | University Hospital, Basel, Switzerland | 2018-11-12 |
| A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects (NCT03770780) | Supernus Pharmaceuticals, Inc. | 2018-11-12 |
| Intratumoral TriMix Injections in Early Breast Cancer Patients (NCT03788083) | Universitair Ziekenhuis Brussel | 2018-11-12 |
| Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers (NCT06879067) | Tiziana Life Sciences LTD | 2018-11-12 |
| The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD) (NCT04468997) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2018-11-12 |
| Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite (NCT03968848) | Acerta Pharma BV | 2018-11-12 |
| Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers (NCT03760848) | Galmed Pharmaceuticals Ltd | 2018-11-12 |
| TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors (NCT03387917) | Swiss Cancer Institute | 2018-11-12 |
| A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z) (NCT03583606) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-11-12 |